Early cholestasis in neonatal lupus erythematosus
Annals of Saudi Medicine. 2011; 31 (1): 80-82
in English
| IMEMR
| ID: emr-103656
ABSTRACT
Neonatal lupus erythematosus is an immune-mediated disease caused by transplacental passage of maternal autoantibodies, primarily anti-Ro [SSA] and anti-La [SSB]. The major clinical manifestations are congenital heart block, cutaneous lupus lesions, and hematologic problems. Hepatic, pulmonary, and neurological involvements are rare. We report a 5-day-old male neonate, born to a clinically asymptomatic mother, presenting with conjugated hyperbilirubinemia, cutaneous lupus lesions, congenital heart block, and thrombocytopenia. Both the neonate and his mother had high titers of antinuclear antibodies [1640], anti-Ro [SSA], and anti-La [SSB] antibodies. The thrombocytopenia improved with prednisolone [2 mg/kg/day] for 14 days. The skin lupus rashes and bilirubin resolved 2 months later, and liver enzymes were completely normal by 6 months
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Ribonucleoproteins
/
Thrombocytopenia
/
Lupus Erythematosus, Cutaneous
/
Infant, Newborn
/
Prednisolone
/
Antibodies, Antinuclear
/
Heart Block
/
Hyperbilirubinemia
/
Lupus Erythematosus, Systemic
Type of study:
Case report
Limits:
Humans
/
Male
Language:
English
Journal:
Ann. Saudi Med.
Year:
2011
Similar
MEDLINE
...
LILACS
LIS